Enchondromatosis and Growth Plate Development.

Journal Article (Journal Article;Review)

PURPOSE OF REVIEW: Enchondroma is a common cartilage benign tumor that develops from dysregulation of chondrocyte terminal differentiation during growth plate development. Here we provide an overview of recent progress in understanding causative mutations for enchondroma, dysregulated signaling and metabolic pathways in enchondroma, and the progression from enchondroma to malignant chondrosarcoma. RECENT FINDINGS: Several signaling pathways that regulate chondrocyte differentiation are dysregulated in enchondromas. Somatic mutations in the metabolic enzymes isocitrate dehydrogenase 1 and 2 (IDH1/2) are the most common findings in enchondromas. Mechanisms including metabolic regulation, epigenetic regulation, and altered signaling pathways play a role in enchondroma formation and progression. Multiple pathways regulate growth plate development in a coordinated manner. Deregulation of the process can result in chondrocytes failing to undergo differentiation and the development of enchondroma.

Full Text

Duke Authors

Cited Authors

  • Zhang, H; Alman, BA

Published Date

  • February 2021

Published In

Volume / Issue

  • 19 / 1

Start / End Page

  • 40 - 49

PubMed ID

  • 33306166

Pubmed Central ID

  • PMC7935756

Electronic International Standard Serial Number (EISSN)

  • 1544-2241

Digital Object Identifier (DOI)

  • 10.1007/s11914-020-00639-7


  • eng

Conference Location

  • United States